Literature DB >> 27028397

Sickle cell disease in western Sudan: genetic epidemiology and predictors of knowledge attitude and practices.

Ahmed A Daak1,2, Elfatih Elsamani3, Eltigani H Ali4, Fatma A Mohamed5, Manar E Abdel-Rahman6, Abozer Y Elderdery7, Octavious Talbot8, Peter Kraft8, Kebreab Ghebremeskel4, Mustafa I Elbashir2, Wafaie Fawzi1.   

Abstract

OBJECTIVE: To investigate the epidemiology of sickle cell disease (SCD) and determinants of knowledge, attitudes and practices (KAP) towards SCD in western Kordofan State, Sudan.
METHODS: A community-based, descriptive, cross-sectional study was conducted in three towns. Three hundred and seventy-two households were polled, and blood samples for haemoglobin phenotyping were collected from 1116 individuals. Sociodemographic, socio-economic and KAP data were collected using investigator-administered questionnaires. Descriptive, frequency distribution and multiple regression analyses were performed.
RESULTS: About 50.9% of the study population were Misseriya tribes. Consanguineous marriages were reported by 67.5% of the households. The highest percentage of homozygous SCD was 2.8% among children under 5 years of age. About 24.9% were carriers of HbS allele (HbAS). HbS allele frequency was highest in children aged 5-11 years (18.3%, CI: 13.7-22.9%) and lowest in males >15 years old (12.0%, CI: 6.1-17.9%). The average HbS frequency across all age groups was 14.5% (95% CI: 12.2-16.8%). The most frequent β-globin gene cluster haplotype was the Cameroon (30.8%), followed by the Benin (21.8%), the Senegal (12.8%) and the Bantu (2.2%) haplotypes. About 17.0% of all-cause child deaths were due to SCD. The estimated change in log odds of having the SS genotype per year increase in age was (-) 0.0058 (95% CI -0.0359, 0.0242). This represents a non-statistically significant 2.9% increase in 5-year mortality for individuals with the SS genotype relative to those with AS and AA genotypes. About 46.9% of the households had poor knowledge, 26.1% had satisfactory knowledge, and 26.9% had good knowledge about sickle cell disease. Mothers' and fathers' educational levels were significant predictors of good knowledge about SCD (P < 0.05). About 48.0% had a satisfactory attitude towards sickle cell disease while 30.7% had poor attitude and only 21.3 showed good attitudes. Poor knowledge about SCD and low socio-economic status were the strongest positive predictors of poor attitude and practices towards SCD (P < 0.01).
CONCLUSIONS: Sickle cell disease is a major health problem in West Kordofan, Sudan. Knowledge, attitude and practices towards the disease are not satisfactory. The development of public health programs is highly recommended to control and manage SCD in western parts of Sudan.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Anemia falciforme; Sudán Occidental; actitudes y prácticas (CAP); attitudes et pratiques (CAP); connaissances; conocimientos; drépanocytose; epidemiología genética; genetic epidemiology; haplotipos; haplotypes; knowledge attitude and practices; ouest du Soudan; sickle cell disease; western Sudan; épidémiologie génétique

Mesh:

Year:  2016        PMID: 27028397     DOI: 10.1111/tmi.12689

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  16 in total

1.  Association between renal function parameters, clinical severity score and mortality risk among adult Sudanese sickle anemia patients.

Authors:  Mohamed Ao Suliman; Alnazeer Ma Hassan; Lamis A Kaddam
Journal:  Am J Blood Res       Date:  2020-12-15

Review 2.  Why social accountability of medical schools in Sudan can lead to better primary healthcare and excellence in medical education?

Authors:  Mohamed H Ahmed; Mohamed Elhassan Abdalla; Mohamed H Taha
Journal:  J Family Med Prim Care       Date:  2020-08-25

3.  Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea.

Authors:  Françoise Bernaudin; Cécile Arnaud; Annie Kamdem; Isabelle Hau; Françoise Lelong; Ralph Epaud; Corinne Pondarré; Serge Pissard
Journal:  Blood Adv       Date:  2018-03-27

4.  Asymmetric Dimethylarginine Levels and Its Correlation to Cerebral Blood Flow in Children with Sickle Cell Anemia.

Authors:  Mohamed El-Shanshory; Nahed Hablas; Hala Nagy; Naglaa Fathy
Journal:  Indian J Hematol Blood Transfus       Date:  2019-03-13       Impact factor: 0.900

5.  Influence of gender norms in relation to child's quality of care: follow-up of families of children with SCD identified through NBS in Tanzania.

Authors:  Julie Makani; Michael Parker; Daima Bukini; Columba Mbekenga; Siana Nkya; Leonard Malasa; Sheryl McCurdy; Karim Manji
Journal:  J Community Genet       Date:  2020-08-12

6.  Quantifying the Levels of Knowledge, Attitude, and Practice Associated with Sickle Cell Disease and Premarital Genetic Counseling in 350 Saudi Adults.

Authors:  Heba M Al-Qattan; Dana F Amlih; Fatima S Sirajuddin; Dalal I Alhuzaimi; Mai S Alageel; Reema M Bin Tuwaim; Farjah H Al Qahtani
Journal:  Adv Hematol       Date:  2019-05-02

7.  Prevalence of sickle cell disease and sickle cell trait among children admitted to Al Fashir Teaching Hospital North Darfur State, Sudan.

Authors:  Mudathir A Adam; Nassreldeen K Adam; Babiker A Mohamed
Journal:  BMC Res Notes       Date:  2019-10-16

8.  Nutritional and Hematological Status of Sudanese Women of Childbearing Age with Steady-state Sickle Cell Anemia.

Authors:  Eltigani Hassan Ali; Salam Alkindi; Mohamed A Osman; Wafa Hilali; Hind M Mirgani; Gareeba Adam; Magdi M Morsi; Izzeldin S Hussein; Kebreab Ghebremeskel
Journal:  Oman Med J       Date:  2021-05-31

9.  Experiences and Problems Encountered by Families of Children with Sickle Cell Anemia.

Authors:  Gülendam Karadağ; Zeynep Güngörmüş; Zeynep Olçar
Journal:  J Caring Sci       Date:  2018-09-01

10.  Severe childhood anemia and emergency blood transfusion in Gadarif Hospital, eastern Sudan.

Authors:  Mohammed Ahmed A Ahmed; Abdullah Al-Nafeesah; Osama Al-Wutayd; Hyder M Mahgoub; Ishag Adam
Journal:  PLoS One       Date:  2019-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.